Cáncer de mama precoz: el caso de la neoadyuvancia en HER2 positivo - page 1

Cáncer de mama precoz: el caso de la

neoadyuvancia en HER2 positivo

Javier Cortes,

Ramon y Cajal University Hospital, Madrid, Spain

Vall d´Hebron Institute of Oncology (VHIO),

Medica Scientia Innovation Research (MedSIR)

Barcelona, Spain

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1 2,3,4,5,6,7,8,9,10,11,...47